There is a predicted steady rise in the prevalence of depression, which will be contributed to by both the growing awareness of mental health issues globally and the current global pandemic, says GlobalData, a leading data and analytics company.
Nneoma Okeke, Pharma Analyst at GlobalData, comments: “In order to effectively combat the rise of prevalent cases of depression, various tools and treatments will be needed to help those with depression live every day the best way possible.”
As World Mental Health day was celebrated in October, with the goal to increase awareness and encourage learning regarding mental health, the impact of the COVID-19 pandemic on mental health will require revised estimates of depression.
Okeke concludes: “Major depressive disorder (MDD), or simply depression, is a common mental health disorder affecting many, and the COVID-19 pandemic appears to have caused an increase in depression rates in the UK, according to surveys from the Office for National Statistics. This may provide insights into shifting trends in this disease space, which showed double the number of total prevalent MDD cases during the pandemic when compared to this period in 2019.”